How medical technology is tackling China’s diabetes crisis
Dan Xu, Chief Marketing Officer at MicroTech Medical believes technology has the power to boost access to medical resources and improve diabetes management. Image: World Economic Forum/Dan Xu
Listen to the article
- China has one of the highest rates of diabetes in the world, and it is worsening. MicroTech provides a technology-based solution to diabetes management to patients worldwide, particularly in China.
- Its Chief Marketing Officer, Dan Xu, believes technology has the power to boost access to medical resources and improve health and patient care.
- As part of the World Economic Forum’s Annual Meeting of the New Champions, she told us about the social impact of bringing new medical technologies to Asia.
When she was pregnant, Dan Xu got diabetes. It’s not uncommon, with the high blood sugar levels often resolving themselves after birth. But it meant weeks of finger pricking and glucose monitoring – time-consuming, painful and often impractical alongside daily life.
This experience became instrumental in her choice to take up the role of Chief Marketing Officer at MicroTech Medical, a China-based company aimed at driving innovation in diabetes management. Through medical devices like continuous glucose monitoring and insulin pumps, the company is aiming to bring more freedom and flexibility to those with diabetes.
Back in 2016, the World Health Organization described the growth of diabetes in China as “explosive”. By 2021, there were an estimated 141 million diabetics in the country – that’s a tenth of the population, the highest level globally.
Without urgent action to reduce lifestyle risk factors like unhealthy diet and lack of physical activity, that number is expected to increase to 150 million by 2040, the WHO added.
China is far from alone in seeing the prevalence of the disease rise though. Middle- and lower-income countries, in particular, are witnessing a growing number of cases. Figures for 2019 show an estimated 2 million people died of diabetes and kidney disease related to diabetes.
"Technologies like MicroTech’s core products offer a minimally invasive approach to disease management and have become widely available in China in recent years," says Dan.
Ahead of the World Economic Forum’s Annual Meeting of the New Champions, Dan told us about the social impact of bringing new medical technologies to Asia, and what it means for the future of healthcare in the region.
This interview has been edited for length and clarity.
What is AMNC, the World Economic Forum's meeting in China?
How are new technologies changing what is possible in healthcare?
This is a very exciting era with fast-developing technologies in the medical sector. Besides health monitoring and wellness, there are exciting developments like robotic-assisted surgery. Not only does it make smaller incisions, reduce scarring and help with faster recovery, but it also enables experts to do surgeries remotely.
Technology is also changing patient education ... empowering the patients to be active participants in taking care of themselves using mobile apps, online platforms and virtual communities.
For instance, we use an AI-empowered chat function to provide knowledge to diabetes patients on how to leverage therapeutic solutions and establish healthy personal habits to manage their health. This approach allows us to serve over 100,000 people at the same time.
What role does technology and innovation play in boosting access to medical resources?
There are three main areas.
The first is online diagnostics. People worldwide can consult with healthcare professionals remotely through video calls, phone calls and online chat. This technology has become especially valuable during COVID-19, allowing individuals to receive medical advice and prescriptions without visiting a clinic. The use of these platforms is growing rapidly in China.
Secondly, it is allowing ‘remote’ patients to make use of monitoring devices and wearable sensors like continuous glucose monitoring systems (CGMS). These devices can collect very crucial healthcare data and transmit it to relatives and healthcare providers for timely intervention and reduced hospital visits. Thousands of patients globally have been helped in this way using MicroTech CGMS.
And third is the use of AI in the research and development of new drugs. This could help lower the cost of research, and shorten its duration, making drugs ultimately more affordable and accessible.
What guiding principles shape your approach to leadership?
I'm a woman leader. And I'm a mother now. I believe that love is the best motivation. I'm impressed to see those excellent professionals showing leadership in their jobs. But I'm also very impressed to see full-time mothers showing leadership at home.
One of my friends is a mother, and she put a continuous glucose monitor on every member of her family – and according to the individual data of different family members, customised their food and exercise. So she is an example of how leadership is everywhere and good leaders can come from anywhere.
How do you ensure social impact is integrated into the overall strategy and operations of the business?
Culture is very important. In MicroTech, we have more women employees than men, and gender equality is a part of our company's culture.
Our yearly marketing plan always has a specific part or project about social impact, which might include collaborating with diabetes foundations and other parties.
One of the key ways for us to measure the effectiveness and outcome of our social impact is the public awareness created around a specific disease and how it changes behaviour.
How do you see Forum's New Champions community helping you achieve broader social impact?
I have been working with the New Champions community for the past five years. It is a great community for enterprises to learn, communicate and build up business networks.
How does the World Economic Forum help mid-sized businesses broaden their social impact?
In recent years more new enterprises focusing on technology and healthcare have joined this community and it is helping our company broaden our horizons and foster business insights.
Don't miss any update on this topic
Create a free account and access your personalized content collection with our latest publications and analyses.
License and Republishing
World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.
The views expressed in this article are those of the author alone and not the World Economic Forum.
Stay up to date:
Global Health
Related topics:
The Agenda Weekly
A weekly update of the most important issues driving the global agenda
You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.
More on Forum InstitutionalSee all
Gayle Markovitz and Vesselina Stefanova Ratcheva
November 21, 2024